Is GPCR or GRDX more undervalued in 2026?

CirclFi compares Structure Therapeutics Inc. (GPCR) and GridAI Technologies Corp. (GRDX) using 13 institutional-grade valuation models. GPCR has a Quality of Company score of 4.1/10 while GRDX scores 4.4/10.

Which is a better buy — GPCR or GRDX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do GPCR and GRDX valuations compare?

GPCR at $39.34 and GRDX at $5.61 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

GPCR vs GRDX Valuation Comparison 2026 — Intrinsic Value Analysis

GPCR

Pharmaceutical Preparations

Structure Therapeutics Inc.

Quality

4.1

out of 10

Value Trap

SAFE

Price

$39.34

Last close

Models

10/13

Active

GRDX

Pharmaceutical Preparations

GridAI Technologies Corp.

Quality

4.4

out of 10

Value Trap

LOW

Price

$5.61

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	GPCR Fair Value	GPCR Upside	GRDX Fair Value	GRDX Upside
Bayesian DCF	Intrinsic	$13.58	-65.5%	$0.69	-87.8%
Earnings Power Value	Intrinsic	$20.74	-54.4%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$14.43	-63.3%	$0.12	-97.8%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for GPCR vs GRDX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

GPCR vs GRDX — Which Stock Is More Undervalued?

GRDX scores higher with a 4.4/10 quality rating vs GPCR's 4.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Structure Therapeutics Inc. (GPCR) and GridAI Technologies Corp. (GRDX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

GPCR currently trades at $39.34 with a QOC of 4.1/10, while GRDX trades at $5.61 with a QOC of 4.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).